Successful use of a tipranavir/ritonavir-based antiretroviral regimen following development of viral resistance to darunavir.
Pierone
Gerald
G
Urban
Theresa
T
Martin
Amber
A
Mieras
Jeffrey
J
Kantor
Chandra
C
D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D000069454:Darunavir; D024882:Drug Resistance, Viral; D006678:HIV / Q000187:drug effects*; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011725:Pyridines / Q000627:therapeutic use*; D011753:Pyrones / Q000627:therapeutic use*; D019438:Ritonavir / Q000627:therapeutic use*; D013449:Sulfonamides / Q000494:pharmacology*; D016896:Treatment Outcome
D044966:Anti-Retroviral Agents; D011725:Pyridines; D011753:Pyrones; D013449:Sulfonamides; D019438:Ritonavir; D000069454:Darunavir; C107201:tipranavir